- Report
- February 2024
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 105 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2023
- 451 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- October 2012
- 1570 Pages
The Rabies Vaccine market is a subset of the Vaccines market, which is a global industry that produces and distributes immunizations to protect against infectious diseases. Rabies Vaccines are used to protect against the rabies virus, which is a fatal disease that is spread through the saliva of infected animals. The Rabies Vaccine market is composed of a variety of products, including pre-exposure and post-exposure vaccines, as well as combination vaccines. These products are used in both humans and animals, and are typically administered by injection.
The Rabies Vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the products. Additionally, the market is subject to a variety of government regulations, including those related to pricing and distribution.
Some companies in the Rabies Vaccine market include Merck & Co., Inc., Sanofi Pasteur, GlaxoSmithKline, and Pfizer, Inc. Show Less Read more